Impaired Erythropoietin Response to Anemia in Patients with Lymphocytic Malignancies

查看全文 作　　者：Bing [1]Han;Yuan-kai [2]Shi;Jun [3]Zhu;Xiao-hui [2]He;Ning-jing [3]Lin;Shu-lan [1]Li;Ti [1]Shen 机构地区：[1]Department of Hematology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences &Peking Union Medical College, Beijing 100730;[2]Department of Medical Oncology, Cancer Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100021;[3]Department of Medical Oncology, Peking University School of Oncology & Beijing Cancer Hospital, Beijing 100036 出　　处：《Chinese Medical Sciences Journal》索引2007年第22卷第3期,共2页 摘　　要：Patients with lymphocytic malignancies like Non-Hodgkin's lymphoma (NHL), multiple myeloma (MM), and chronic lymphocytic leukemia (CLL) are often complicated with anemia. In this prospective study, we devised a carefully controlled erythropoietin (Epo) level measurement in anemic or non-anemic patients with lymphocytic malignancies, in order to determine whether the response of Epo was decreased in anemic patients. 关 键 词：促红细胞生成素 淋巴细胞 贫血 治疗